Holen Sie sich die Stockscreener-App
1.75
1.69%
-0.03
Schlusskurs vom Vortag:
$1.78
Offen:
$1.73
24-Stunden-Volumen:
63,510
Relative Volume:
0.10
Marktkapitalisierung:
$41.01M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-9.64M
KGV:
-3.3169
EPS:
-0.5276
Netto-Cashflow:
$-6.76M
1W Leistung:
-7.41%
1M Leistung:
-20.45%
6M Leistung:
-56.25%
1J Leistung:
-66.15%
1-Tages-Spanne:
$1.65
$1.77
1-Wochen-Bereich:
$1.65
$2.07
52-Wochen-Spanne:
$1.35
$10.00
Genenta Science Spa Adr Stock (GNTA) Company Profile
Firmenname
Genenta Science Spa Adr
Sektor
Branche
Telefon
-
Adresse
-
Vergleichen Sie GNTA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
GNTA
Genenta Science Spa Adr
|
1.75 | 41.71M | 0 | -9.64M | -6.76M | -0.5276 |
|
VRTX
Vertex Pharmaceuticals Inc
|
444.64 | 110.88B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
726.21 | 72.79B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
890.11 | 54.76B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
404.46 | 54.85B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
189.85 | 41.41B | 447.02M | -1.18B | -906.14M | -6.1812 |
Genenta Science Spa Adr Stock (GNTA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2023-06-29 | Fortgesetzt | ROTH MKM | Buy |
| 2022-07-25 | Eingeleitet | H.C. Wainwright | Buy |
| 2022-01-13 | Eingeleitet | Maxim Group | Buy |
Genenta Science Spa Adr Aktie (GNTA) Neueste Nachrichten
Return on equity % of Genenta Science SpA Sponsored ADR – LSX:A3C9EK - TradingView
Healthy Upside Potential: Genenta Science SpA ADR (GNTA) - Setenews
Genenta Science stock soars after update on glioblastoma treatment study By Investing.com - Investing.com Australia
Genenta Science stock soars after update on glioblastoma treatment study - Investing.com
Genenta Reports Long-Term Survival Trends and Immune Findings in Brain Tumor (GBM) Trial - GlobeNewswire Inc.
Genenta Science (NASDAQ:GNTA) Shares Down 3.4% – Should You Sell? - Defense World
Candlestick signals on Genenta Science S.p.A. Depositary Receipt stock todayProduct Launch & Short-Term Trading Opportunity Alerts - newser.com
Analysts Are Bullish on These Healthcare Stocks: Altimmune (ALT), Dogwood Therapeutics (DWTX) - The Globe and Mail
Genenta Science Expands Board and Corporate Purpose Following Shareholders’ Meeting - MSN
Weiss Ratings Reiterates Sell (D-) Rating for Genenta Science (NASDAQ:GNTA) - MarketBeat
Genenta Science (NASDAQ:GNTA) Stock Price Down 4.7%What's Next? - MarketBeat
Genenta Science Appoints New Board Member and Confirms CEO - MSN
Genenta Science Secures $15 Million in Registered Direct Offering - The Globe and Mail
Why Teradyne Shares Are Trading Higher By More Than 20%; Here Are 20 Stocks Moving Premarket - inkl
U.S. shares higher at close of trade; Dow Jones Industrial Average up 0.71% - Investing.com UK
United States shares higher at close of trade; Dow Jones Industrial Average up 0.71% - Investing.com India
Leadership Change at Genenta Science SpA: Dr. Galimi Appointed Acting CMO - MSN
U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.71% - Investing.com
Genenta Science stock plunges after $15 million ADS offering - Investing.com
Genenta Science stock plunges after $15 million ADS offering By Investing.com - Investing.com South Africa
Genenta Science appoints Dr. Francesco Galimi to board and approves 2024 financials By Investing.com - Investing.com South Africa
Genenta Science appoints Dr. Francesco Galimi to board and approves 2024 financials - Investing.com Philippines
Why Avidity Biosciences Shares Are Trading Higher By Around 42%; Here Are 20 Stocks Moving Premarket - Benzinga
U.S. shares higher at close of trade; Dow Jones Industrial Average up 1.01% - Investing.com UK
U.S. stocks higher at close of trade; Dow Jones Industrial Average up 1.01% - Investing.com
United States shares higher at close of trade; Dow Jones Industrial Average up 1.01% - Investing.com India
US Stock Market today: Dow, Nasdaq, S&P 500 open higher as US inflation data fuels Fed rate cut bets — Details here - Mint
Genenta Science Reports Reduced Losses and Strengthened Balance Sheet for H1 2025 - TipRanks
Genenta Science S.p.A. Unsponsored ADR (NASDAQ:GNTA) Short Interest Update - MarketBeat
Can Genenta Science S.p.A. (Common Stock) (K5F) stock hold up in economic slowdownGap Down & Community Driven Trade Alerts - newser.com
Analysts Are Bullish on Top Healthcare Stocks: Evaxion Biotech (EVAX), Azitra Inc (AZTR) - The Globe and Mail
Genenta Science (NASDAQ:GNTA) Stock Price Down 1.9%Here's What Happened - MarketBeat
Analyzing Genenta Science S.p.A. Depositary Receipt with multi timeframe chartsWeekly Risk Summary & Short-Term Swing Trade Alerts - newser.com
Wall Street Analysts Are Bullish on Top Healthcare Picks - The Globe and Mail
Genenta Science S.p.A. Announces Shareholders’ Meeting for Strategic Amendments - TipRanks
Genenta Science (NASDAQ:GNTA) Trading 7.4% HigherHere's Why - MarketBeat
Finanzdaten der Genenta Science Spa Adr-Aktie (GNTA)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.45%
0.12%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):